By AuntMinnie.com staff writers

August 31, 2017 -- iCAD has received approval from the China Food and Drug Administration (CFDA) for the company's Xoft Axxent balloon applicators for the treatment of early-stage breast cancer.

The Xoft Axxent balloon applicators are part of iCAD's Xoft Axxent electronic brachytherapy system for intraoperative radiation therapy for certain patients with early-stage breast cancer. With this approval, all of iCAD's Xoft products are now available to clinicians and patients in China.

The Xoft system already has clearance from the U.S. Food and Drug Administration (FDA) to treat cancer anywhere in the body, including early-stage breast cancer, nonmelanoma skin cancer, and gynecological cancers.


Copyright © 2017 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: